推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

AMERICAN JOURNAL OF HEMATOLOGY

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 AM J HEMATOL最新评论:三天 (2024-08-16)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


AMERICAN JOURNAL OF HEMATOLOGY期刊基本信息Hello,您是该期刊的第36904位访客


基本信息 登录收藏
期刊名字AMERICAN JOURNAL OF HEMATOLOGYAMERICAN JOURNAL OF HEMATOLOGY

AM J HEMATOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.8
51人评分
我要评分

声誉
8.8

影响力
6.8

速度
9.3

期刊ISSN0361-8609
微信扫码收藏此期刊
E-ISSN1096-8652
2023-2024最新影响因子
(数据来源于搜索引擎)
10.1 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:5.893
2023-2024自引率5.90%点击查看自引率趋势图
五年影响因子10.1
JCI期刊引文指标 1.83
h-index 92
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
15.702.6072.451
学科分区排名百分位
大类:Medicine
小类:Hematology
Q19 / 137

期刊简介
The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652
期刊投稿网址http://mc.manuscriptcentral.com/ajh
期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足AMERICAN JOURNAL OF HEMATOLOGY的语言要求,还能让AMERICAN JOURNAL OF HEMATOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被AMERICAN JOURNAL OF HEMATOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030
出版商Wiley-Liss Inc.
涉及的研究方向医学-血液学
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份1976
年文章数 174点击查看年文章数趋势图
Gold OA文章占比29.12%
研究类文章占比:
文章 ÷(文章 + 综述)
89.66%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:HEMATOLOGYSCIEQ18/97
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:HEMATOLOGYSCIEQ110/97
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区3区
HEMATOLOGY
血液学
2区2区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区3区
HEMATOLOGY
血液学
4区2区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区1区
HEMATOLOGY
血液学
3区2区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0361-8609%5BISSN%5D
平均审稿速度网友分享经验:
一般,3-6周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在AMERICAN JOURNAL OF HEMATOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 AMERICAN JOURNAL OF HEMATOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 AMERICAN JOURNAL OF HEMATOLOGY中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
AMERICAN JOURNAL OF HEMATOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of Hematology & Oncology6048.10
    BLOOD42623.60
    LEUKEMIA17618.10
    HAEMATOLOGICA12514.10
    BLOOD REVIEWS8513.80
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY11111.00
    BRITISH JOURNAL OF HAEMATOLOGY1728.60
    SEMINARS IN HEMATOLOGY886.20
    HEMATOLOGICAL ONCOLOGY424.20
    CURRENT OPINION IN HEMATOLOGY906.60
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE669680
    BIOMATERIALS561771
    BIOMEDICINE & PHARMACOTHERAPY545133
    Frontiers in Pharmacology509215
    Journal of Materials Chemistry B498325
    Frontiers in Immunology485384
    COMPUTERS IN BIOLOGY AND MEDICINE465123
    JOURNAL OF ETHNOPHARMACOLOGY459933
    COLLOIDS AND SURFACES B-BIOINTERFACES435241
    Frontiers in Oncology431274
  •  

    AMERICAN JOURNAL OF HEMATOLOGY AMERICAN JOURNAL OF HEMATOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia

    Author: Wang, Qian; Cai, Wen-zhi; Wang, Qin-rong; Zhu, Ming-qing; Yan, Ling-zhi; Yu, Yan; Bao, Xie-bing; Shen, Hong-jie; Yao, Hong; Xie, Jun-dan; Zhang, Tong-tong; Zhang, Ling; Xu, Xiao-yu; Shan, Zhe; Liu, Hong; Cen, Jian-nong; Liu, Dan-dan; Pan, Jin-lan; Lu, Da-ru; Chen, Jia; Xu, Yang; Zhang, Ri; Wang, Ying; Xue, Sheng-li; Miao, Miao; Han, Yue; Tang, Xiao-wen; Qiu, Hui-ying; Sun, Ai-ning; Huang, Jin-yan; Dai, Hai-ping; Wu, De-pei; Chen, Su-ning
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 1, pp. 66-78. DOI: 10.1002/ajh.26758
        PubMed      DOI
    2.Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma

    Author: Yang, Peiyu; Chen, Haimin; Liang, Xinyue; Xu, Weiling; Yu, Shanshan; Huang, Wenyang; Yi, Xingcheng; Guo, Qiang; Tian, Mengru; Yue, Tingting; Li, Mengyao; Zhang, Yingjie; Zhang, Mengxue; Yan, Yurong; Hu, Zhongli; Kumar, Shaji K.; Zhou, Fan; Dai, Yun; Jin, Fengyan
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 2, pp. 251-263. DOI: 10.1002/ajh.26774
        PubMed      DOI
    3.Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT: An open-label, multicenter, randomized phase 3 trial

    Author: Liu, Hui; Huang, Fen; Zhang, Yu; Wu, Meiqing; Xu, Na; Fan, Zhiping; Sun, Zhiqiang; Li, Xudong; Lin, Dongjun; Xiong, Yiying; Liu, Xiaodan; Lin, Ren; Shi, Pengcheng; Xu, Jun; Wang, Zhixiang; Li, Xiaofang; Sun, Jing; Liu, Qifa; Xuan, Li
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 3, pp. 408-412. DOI: 10.1002/ajh.26800
        PubMed      DOI
    4.The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases

    Author: Cao, Yigeng; Gong, Xiaowen; Feng, Yahui; Wang, Mingyang; Hu, Yu; Liu, Huilan; Liu, Xueou; Qi, Saibing; Ji, Yanping; Liu, Fang; Zhu, Huaiping; Guo, Wenwen; Shen, Qiujin; Zhang, Rongli; Zhao, Ningning; Zhai, Weihua; Song, Xiaoqiang; Chen, Xin; Geng, Liangquan; Zheng, Xuetong; Ma, Qiaoling; Tang, Baolin; Wei, Jialin; Huang, Yong; Ren, Yuanyuan; Song, Kaidi; Yang, Donglin; Pang, Aiming; Yao, Wen; He, Yi; Shang, Yue; Wan, Xiang; Zhang, Wei; Zhang, Song; Sun, Guangyu; Feng, Sizhou; Zhu, Xiaofan; Han, Mingzhe; Song, Zhen; Guo, Ye; Sun, Zimin; Jiang, Erlie; Chen, Junren
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 2, pp. 309-321. DOI: 10.1002/ajh.26792
        PubMed      DOI
    5.Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study

    Author: Cui, Lei; Wang, Chan-Juan; Lian, Hong-Yun; Zhang, Li; Ma, Hong-Hao; Wang, Dong; Chen, Fen-Fen; Zhang, Qing; Yang, Ying; Wei, Ang; Huang, Xiao-Tong; Zhu, Ting; Wang, Tian-You; Li, Zhi-Gang; Zhang, Rui
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 4, pp. 598-607. DOI: 10.1002/ajh.26829
        PubMed      DOI
    6.Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study

    Author: Xu, Wei; Zhou, Keshu; Wang, Tingyu; Yang, Shenmiao; Liu, Lihong; Hu, Yu; Zhang, Wei; Ding, Kaiyang; Zhou, Jianfeng; Gao, Sujun; Xu, Bing; Zhu, Zunmin; Liu, Ting; Zhang, Huilai; Hu, Jianda; Ji, Chunyan; Wang, Shunqing; Xia, Zhongjun; Wang, Xin; Li, Yan; Song, Yongping; Ma, Shuo; Tang, Xinran; Zhang, Bin; Li, Jianyong
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 4, pp. 571-579. DOI: 10.1002/ajh.26826
        PubMed      DOI
    7.Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial

    Author: Qiu, Kun-yin; Wang, Jia-yi; Huang, Li-bin; Li, Chang-gang; Xu, Lu-hong; Liu, Ri-yang; Chen, Hui-qin; Ruan, Yong-sheng; Zhen, Zi-jun; Li, Chi-kong; Fang, Jian-pei
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26910
        PubMed      DOI
    8.Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation

    Author: Tang, Yaqiong; Zhang, Ziyan; Liu, Silu; Yao, Yifang; Pan, Tingting; Qi, Jiaqian; Kang, Huizhu; Liu, Yuejun; Cai, Chengsen; Zhou, Meng; He, Xuefeng; Hu, Xiaohui; Ma, Xiao; Wu, Depei; Han, Yue
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26903
        PubMed      DOI
    9.A phase II study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first-line therapy in patients with newly diagnosed, stage I-II extranodal natural-killer/T-cell lymphoma

    Author: Sun, Peng; Li, Yajun; Li, Cong; Ren, Kexing; Wang, Yu; Yang, Hang; Jiang, Wenqi; Zou, Liqun; Yang, Haiyan; Zhou, Hui; Li, Zhi-Ming
    Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26922
        PubMed      DOI
    10.Iron homeostasis in pregnancy and spontaneous abortion.

    Author: Guo Y1,2,3, Zhang N4, Zhang D2,3, Ren Q1,5, Ganz T6, Liu S1,5, Nemeth E6.
    Journal: Am J Hematol. 2019 Feb;94(2):184-188. doi: 10.1002/ajh.25341. Epub 2018 Nov 26.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共28


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室